Europe Regenerative Medicines Market

Europe Regenerative Medicines Market by Type of Technologies (Tissue Engineering, Stem Cell Therapy, Biomaterial, and Others), Applications (Cardiovascular, Bone Graft Substitutes, Central Nervous System, Osteoarticular Diseases, Dermatology, and Others), and Geography (The UK, Germany, Italy, France, Spain, and Rest of Europe) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-3450
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 199
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Europe regenerative medicines market size is projected to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing technological advancements and innovations in regenerative medicines.

Europe Regenerative Medicines Market summary

Regenerative medicine deals with the process of replacing, engineering, and regenerating body cells, tissues, and organs to restore the normal functioning. The regenerative processes closely relate with the engineering damaged tissues by stimulating the repair mechanisms of the body in order to functionally heal the previously irreparable tissues or organs. The regenerative medicine seeks to replace the tissue or organs damaged by disease, trauma, and congenital issues unlike the current clinical strategy that primarily focuses on treating the symptoms. Regenerative medicine also includes the possibility of growing tissues and organs in the laboratory. When the cell source for a regenerated organ is derived from the body tissue or cells, the challenge of organ transplant rejection can be avoided. Some of the biomedical approaches in the field of regenerative medicine involve the use of stem cells such as injection of stem cells or progenitor cells obtained through directed differentiation. The tools used for regenerative therapies are tissue engineering, medical devices, cellular therapies, and artificial organs. The combination of regenerative processes and medicines can amplify the natural healing process and revert back the function of a permanently damaged organ. Regenerative medicine is the field that associates the experts in biology, engineering, robotics, genetics, chemistry, computer science, medicine, and other fields together to generate solutions over the most challenging medical problems faced by the humankind. The promising field of regenerative medicine proved to be a boon for restoring the structure and function of damaged tissues and organs. The field has aided in creating effective solutions for organs that become permanently damaged.

The COVID-19 pandemic had a significant impact on the dynamics of various industries. The outbreak of coronavirus resulted into nationwide lockdowns that disrupted the supply of healthcare facilities and manufacturing of medical devices. The pandemic situation witnessed denied wound care services, cancelled or postponed elective surgeries, and increasing skin injuries in COVID-19 medical care providers. Therefore, the stringent regulations and slowdown in economy hampered the growth of the regenerative medicines market.

Market Trends, Drivers, Restraints and Opportunities

  • Rising adoption of stem-cell technologies, gene therapies, and tissue engineering are the major factor propelling the market expansion during the projected period.
  • Increasing prevalence of chronic diseases, genetic disorders, and cancer is estimated to positively influence the market growth in the coming years.
  • Growing applications of stem-cell technologies in the treatment of various diseases is anticipated to expand the market during the forecast period.
  • High cost associated with cell and gene therapies is expected to hamper the growth of the market during the projected timeline.
  • Rising industrial investments, increasing new product launches by the key players, and growing focus on research & development activities are expected to create numerous opportunities for the market growth during the forecast period.

Scope of the Report

The report on the Europe regenerative medicines market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Europe Regenerative Medicines Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Type of Technologies (Tissue Engineering, Stem Cell Therapy, Biomaterial, and Others) and Applications (Cardiovascular, Bone Graft Substitutes, Central Nervous System, Osteoarticular Diseases, Dermatology, and Others)

Geographical Scope

The UK, Germany, Italy, France, Spain, and Rest of Europe

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Cook Biotech Incorporated; Merck KGaA; Thermo Fisher Scientific; Integra LifeSciences Corporation; and Smith & Nephew (Osiris Therapeutics)

Europe Regenerative Medicines Market Segment Insights

Stem cell therapy segment is anticipated to register a substantial CAGR

Based on type of technologies, the market is segmented into tissue engineering, stem cell therapy, biomaterial, and others. The stem cell therapy segment is anticipated to register a substantial CAGR during the forecast period owing to the increasing demand for cell & gene therapies and rising stem cell research activities. Furthermore, the ease of manufacturing & production processes and the increasing availability of novel stem cell products are expected to propel the growth of the market segment in the coming years. On the other hand, the tissue engineering segment is anticipated to hold a significant market share during the forecast period due to the increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders. Moreover, the rising funding for the research & development activities for regenerative medicine products and therapies are projected to boost the market growth during the projected timeline.

Europe Regenerative Medicines Market type of technologies

Cardiovascular segment is expected to grow at a rapid pace

On the basis of applications, the market is segregated into cardiovascular, bone graft substitutes, central nervous system, osteoarticular diseases, dermatology, and others. The cardiovascular segment is expected to grow at a rapid pace during the projected period due the increasing disposable income and rising prevalence of heart failure. However, the bone graft substitutes segment is expected to exhibit a substantial growth during the forecast period owing to the rising prevalence of orthopedic diseases, increasing number of stem cell research projects, and growing geriatric population. Furthermore, the growing number of clinical researches and trials are anticipated to propel the growth of the market segment during the forecast period.

Europe Regenerative Medicines Market applications

Germany market is anticipated to constitute a key market share

In terms of geography, the Europe regenerative medicines market is classified as the UK, Germany, Italy, France, Spain, and Rest of Europe. Germany market is anticipated to constitute a key share of the market during the projected period owing to the rising industrial investments for stem cell banking, tissue engineering, and drug discovery in the country. Moreover, the increasing high adoption of cell immunotherapies and stem cell therapy for the treatment of cancer and chronic diseases are expected to boost the market growth during the forecast period. On the other hand, the market in France is anticipated to exhibit a robust CAGR during the forecast period due to growing demand for innovative product launches and increasing expansion of the healthcare sector.

Segments

Segments Covered in the Report
The Europe regenerative medicines market has been segmented on the basis of
Type of Technologies

  • Tissue Engineering
  • Stem Cell Therapy
  • Biomaterial
  • Others

Applications

  • Cardiovascular
  • Bone Graft Substitutes
  • Central Nervous System
  • Osteoarticular Diseases
  • Dermatology
  • Others

Geography

  • The UK
  • Germany
  • Italy
  • France
  • Spain
  • Rest of Europe

Key Players

  • Cook Biotech Incorporated
  • Merck KGaA
  • Thermo Fisher Scientific
  • Integra LifeSciences Corporation
  • Smith & Nephew (Osiris Therapeutics)

 

Competitive Landscape

Key players competing in the Europe regenerative medicines market are Cook Biotech Incorporated; Merck KGaA; Thermo Fisher Scientific; Integra LifeSciences Corporation; and Smith & Nephew (Osiris Therapeutics). The companies are focusing on business strategies, increasing investments, and new product launches in order to expand their market shares.

In October 2021, Thermo Fisher Scientific announced its clinical and research lab innovations at AACC Annual Scientific Meeting & Clinical Lab Expo 2021. The company aimed to expand the portfolio of instruments, controls, assays, and related technologies for increasing performance, speed, and flexibility within the research and clinical labs. The company donated equipment for AACC's COVID-19 Immunity Study to enable the onsite serology testing for analyzing the immune responses for SARS-CoV-2 vaccination among participants.

In July 2021, Integra LifeSciences Corporation announced its SurgiMend® collagen matrix for soft tissue reconstruction and received an innovative technology contract from Vizient, Inc. The contract was awarded based on the recommendation by hospital experts of Vizient’s member-led councils and improved the business operations of health care organizations. The company aimed to provide the clinicians with advanced clinical solutions with a variety of shapes & sizes for a wide range of soft tissue repair and regeneration. The developments in tissue repair and regeneration applications enhanced clinical care, patient safety, health care worker safety, and patient outcomes.

In September 2018, Cook Biotech Incorporated and AcuityBio Inc. announced agreements for strategic collaboration and development of AcuityBio’s ABC103. The companies aimed to collaborate in the advancement of AcuityBio’s ABC103, a leading product for lung cancer that will be used to utilize Cook Biotech’s proprietary extracellular matrix (ECM) technology.

Europe Regenerative Medicines Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Regenerative Medicines Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Regenerative Medicines Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Regenerative Medicines Market - Supply Chain
  4.5. Global Regenerative Medicines Market Forecast
     4.5.1. Regenerative Medicines Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Regenerative Medicines Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Regenerative Medicines Market Absolute $ Opportunity
5. Global Regenerative Medicines Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Regenerative Medicines Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Regenerative Medicines Demand Share Forecast, 2019-2026
6. North America Regenerative Medicines Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Regenerative Medicines Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Regenerative Medicines Demand Share Forecast, 2019-2026
7. Latin America Regenerative Medicines Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Regenerative Medicines Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Regenerative Medicines Demand Share Forecast, 2019-2026
8. Europe Regenerative Medicines Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Regenerative Medicines Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Regenerative Medicines Demand Share Forecast, 2019-2026
9. Asia Pacific Regenerative Medicines Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Regenerative Medicines Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Regenerative Medicines Demand Share Forecast, 2019-2026
10. Middle East & Africa Regenerative Medicines Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Regenerative Medicines Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Regenerative Medicines Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Regenerative Medicines Market: Market Share Analysis
  11.2. Regenerative Medicines Distributors and Customers
  11.3. Regenerative Medicines Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Cook Biotech Incorporated
     11.4.2. Merck KGaA
     11.4.3. Thermo Fisher Scientific
     11.4.4. Integra LifeSciences Corporation
     11.4.5. Smith & Nephew (Osiris Therapeutics)

Segments Covered in the Report
The Europe regenerative medicines market has been segmented on the basis of
Type of Technologies

  • Tissue Engineering
  • Stem Cell Therapy
  • Biomaterial
  • Others

Applications

  • Cardiovascular
  • Bone Graft Substitutes
  • Central Nervous System
  • Osteoarticular Diseases
  • Dermatology
  • Others

Geography

  • The UK
  • Germany
  • Italy
  • France
  • Spain
  • Rest of Europe

Key Players

  • Cook Biotech Incorporated
  • Merck KGaA
  • Thermo Fisher Scientific
  • Integra LifeSciences Corporation
  • Smith & Nephew (Osiris Therapeutics)

 

Key players competing in the Europe regenerative medicines market are Cook Biotech Incorporated; Merck KGaA; Thermo Fisher Scientific; Integra LifeSciences Corporation; and Smith & Nephew (Osiris Therapeutics). The companies are focusing on business strategies, increasing investments, and new product launches in order to expand their market shares.

In October 2021, Thermo Fisher Scientific announced its clinical and research lab innovations at AACC Annual Scientific Meeting & Clinical Lab Expo 2021. The company aimed to expand the portfolio of instruments, controls, assays, and related technologies for increasing performance, speed, and flexibility within the research and clinical labs. The company donated equipment for AACC's COVID-19 Immunity Study to enable the onsite serology testing for analyzing the immune responses for SARS-CoV-2 vaccination among participants.

In July 2021, Integra LifeSciences Corporation announced its SurgiMend® collagen matrix for soft tissue reconstruction and received an innovative technology contract from Vizient, Inc. The contract was awarded based on the recommendation by hospital experts of Vizient’s member-led councils and improved the business operations of health care organizations. The company aimed to provide the clinicians with advanced clinical solutions with a variety of shapes & sizes for a wide range of soft tissue repair and regeneration. The developments in tissue repair and regeneration applications enhanced clinical care, patient safety, health care worker safety, and patient outcomes.

In September 2018, Cook Biotech Incorporated and AcuityBio Inc. announced agreements for strategic collaboration and development of AcuityBio’s ABC103. The companies aimed to collaborate in the advancement of AcuityBio’s ABC103, a leading product for lung cancer that will be used to utilize Cook Biotech’s proprietary extracellular matrix (ECM) technology.

Europe Regenerative Medicines Market keyplayers

Buy Report